Trustees Of Tufts College

Trustees of Tufts College, doing business as Tufts University School of Medicine, a private tax-exempt research institution headquartered in Boston, Massachusetts, acts as a prime recipient on federal research grants and a prime contractor on federal research contracts supporting biomedical research across infectious diseases, neuroscience, cancer, cardiovascular health, aging, and clinical medicine. The institution is a major research university without SBA certifications; it competes in full-and-open federal research funding based on scientific reputation and specialized research infrastructure rather than procurement-set-aside advantage.

Tufts' federal footprint centers overwhelmingly on biomedical research grants and research contracts. NIAID dominates the customer base—the National Institute of Allergy and Infectious Diseases accounts for 217 awards carrying $251 million in combined potential value across the recent award portfolio, anchored by a $146.3 million single-award Indefinite Delivery Contract awarded July 15, 2024, for preclinical models of infectious diseases (small animal models, non-human primate models, replacement animal models, and specialized research reagents) running through July 14, 2031. The Department of the Navy's Bureau of Medicine and Surgery places frequent delivery orders for tuition and fees at Tufts University School of Medicine, totaling 104 awards with $26.1 million combined potential value—typical orders range from $115 thousand to $328 thousand for individual fall or full-year medical education placements. Outside health research, USAID funds overseas health security and agricultural development work, with $17 million combined potential value across 30 awards. Recent representative grants include NIH project grants in infectious diseases (Lyme disease mechanisms, herpesvirus viral fusion, Acinetobacter baumannii antibiotic resistance, Clostridioides difficile spore germination), neuroscience (astrocyte function, tau aggregates, homeostatic plasticity), cancer biology (Epstein-Barr virus-driven lymphomagenesis, osteosarcoma biomarkers), and cardiovascular health (mitral valve prolapse, DNA methylation and heart disease). Tufts also receives NHLBI funding for cardiovascular research ($1.12 million multiethnic and multiomics analysis of DNA methylation and cardiovascular health), NIA funding for aging biology and senescence, NIDA funding for opioid addiction mechanisms, and NCI funding for cancer immunotherapy and precision oncology.

Tufts operates 89% as a prime across its recent federal award portfolio (1,377 of 1,544 awards). Activity shows 96 distinct customer agencies served, with awards totaling $331.3 million in combined potential value but $2.12 billion in combined obligated dollars—a pattern typical of large multi-year research grants and contracts where cumulative spend across renewal periods exceeds the original potential ceiling. Annual award count has remained between 69 and 96 over the past five fiscal years, with 2024 showing peak activity at 96 awards. In the next twenty-four months, 114 awards carrying $2.7 million combined potential value reach ultimate completion, triggering recompete exposure in NIH core research portfolios. The Navy's tuition-and-fee delivery orders, issued annually, represent recurring revenue streams with modest individual ceilings but high predictability.

SCI-reportable federal service contracts show modest scale: $2.8 million in invoiced revenue across FY2022–FY2025 as prime contractor, with 4–5 FTEs reported annually supporting these contracts. Median government-paid hourly rates on SCI-reportable prime contracts run $79.15/hr, reflecting educational-institution pricing and research-support labor rather than commercial billing rates; 10th-percentile rates are $20.78/hr and 90th-percentile rates $108.23/hr. SCI sub-engagement is minimal (0% sub-hours share), indicating Tufts delivers most SCI-reportable service work directly rather than through subcontractors. The wider federal portfolio—dominated by research grants and research contracts—operates outside SCI thresholds; these are largely investigator-initiated grants in the $200 thousand to $1 million range carrying direct and indirect costs payable per federal negotiated rates rather than hourly service rates.

Tufts subcontracts to and receives sub-awards from peer research institutions including Massachusetts General Hospital, Jackson Laboratory, Boston University, Harvard Medical School, University of Pennsylvania, Yale, Duke, and Mayo Clinic on multi-site infectious-disease, aging, and cancer studies. The institution maintains a graduate-training infrastructure and operates the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA), specialized laboratory facilities for vitamin K analysis and metabolomics, and dedicated preclinical animal care and breeding programs that anchor its role as a preferred prime for long-duration NIH research contracts and grants. Teaming on federal work is predominantly as lead prime rather than co-prime or subcontractor, reflecting the institution's scale, reputation, and research-infrastructure assets.